Sanofi ADR

Sanofi ADR

Yahoo Finance • yesterday

CNS Summit Announces Sanofi as No. 1 in the 2026 Digital Innovation Index

BOSTON, Nov. 4, 2026 /PRNewswire/ -- Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index, developed in collaboration with IDEA Pharma, a division of SAI MedPartners, placing in the top three in all three categories. The ran... Full story

Yahoo Finance • 2 days ago

Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272

Nurix Therapeutics, Inc. BRISBANE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on targeted protein degradation medicines, today announced that Sanof... Full story

Yahoo Finance • 3 days ago

BTK Inhibitors Market to Expand During the Forecast Period (2026–2036) as Targeted Treatments Advance Across B-Cell Malignancies and Autoimmune Disorders | DelveInsight

DelveInsight Business Research LLP DelveInsight's report assesses the BTK inhibitors market across the 7MM, with steady growth anticipated through 2036. This growth is driven by the increasing prevalence of B-cell malignancies, the establ... Full story

Yahoo Finance • 6 days ago

Regeneron (REGN) stock trades up, here is why

Regeneron (REGN) stock trades up, here is why What happened? Shares of biotech company Regeneron (NASDAQ:REGN) jumped 11.5% in the afternoon session after the company reported a 36% increase in third-quarter 2026 revenue to $5.1 billion,... Full story

Yahoo Finance • 6 days ago

EssilorLuxottica Stock And Eurozone Healthcare Giants Worth Watching Now

Eurozone growth just cooled to 0.4% in Q3, yet still beat forecasts, and that mix of resilience and slowdown is quietly reshaping where money could flow next. Some businesses may benefit if investors rethink how far the ECB can cut, while... Full story

Yahoo Finance • 6 days ago

European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading

European equities traded in the US as American depositary receipts were down 0.59% to 1,896.05 on th Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • 7 days ago

Stock market today: Dow, S&P 500, Nasdaq futures fall as Amazon, Intel earnings rattle investors

US stock futures sank in the final trading day of the month as earnings from Amazon (AMZN) and Alphabet (GOOG, GOOGL) this week rekindled concerns about the amount of money Big Tech is spending on its AI ambitions. Contracts for the Nasda... Full story

Yahoo Finance • 7 days ago

Sanofi lifts profit outlook on strong Dupixent sales

[Night Sanofi office building in Berlin, Germany.] Panama7/iStock Editorial via Getty Images Sanofi (SNY [https://seekingalpha.com/symbol/SNY]) raised its full-year 2026 guidance after reporting stronger-than-expected third-quarter result... Full story

Yahoo Finance • 7 days ago

Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology

Licensable perturbation dataset to include transcriptomes and proteomic secretomes for understanding the human immune response SEATTLE & MONTREAL, October 29, 2026--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and... Full story

Yahoo Finance • 11 days ago

Novartis MS drug remibrutinib cuts relapses, no liver safety signal in trials

Investing.com -- Shares of Swiss drugmaker Novartis slipped on Monday, as the company said on Friday its experimental multiple sclerosis drug remibrutinib cut relapses by roughly a third versus Sanofi-owned rival Aubagio (teriflunomide) in... Full story

Yahoo Finance • 13 days ago

These French Companies Have Global Reach. The Stocks Are Bargains.

Some investors are looking beyond turmoil in France for companies that depend little on their domestic market. Continue Reading... Full story

Yahoo Finance • 16 days ago

ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics

CAMBRIDGE, England, October 20, 2026--(BUSINESS WIRE)--ScionxBio (the "company", operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering n... Full story

Yahoo Finance • 17 days ago

Insmed Appoints Two New Directors to Its Board

—Paul Hudson, Former CEO of Sanofi and Novartis Pharmaceuticals, and Utpal Koppikar, CFO of Verily Health and Veteran Biopharma Finance Leader, Join as New Independent Directors— BRIDGEWATER, N.J., Oct. 20, 2026 /PRNewswire/ -- Insmed Inc... Full story

Yahoo Finance • 17 days ago

3 Eurozone Defensive Stocks With Low Debt And Steady Cash Flow

French bond yields near 4.9% and a wider France to Germany spread have pushed eurozone risk back into the spotlight. Yet that same stress can shine a light on quieter businesses with low debt and steadier cash flows. When market focus swin... Full story

Yahoo Finance • 17 days ago

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

European equities traded in the US as American depositary receipts opened the week lower late Monday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 21 days ago

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index rising 2.3% and the S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 24 days ago

Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up

Investing.com -- Nurix Therapeutics Inc (NASDAQ:NRIX) reported third quarter fiscal 2026 financial results on Monday, with revenue of $673.1 million, up significantly from $7.9 million in the same quarter last year. The company posted adju... Full story

Yahoo Finance • 24 days ago

Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Nurix Therapeutics, Inc. Dosed first patient in registrational Phase 3 DAYBreak CLL-306 trial comparing bexobrutideg with pirtobrutinib in relapsed/refractory CLL/SLL Advanced bexobrutideg combination strategy with initiation of recruiti... Full story

Yahoo Finance • 28 days ago

Retension Pharmaceuticals prices upsized IPO at $12 per share

[IPO Concept with Stock Market Graphs] AlexSecret * Retension Pharmaceuticals (RTSN [https://seekingalpha.com/symbol/RTSN]) priced its upsized IPO at $12 per share. * The clinical-stage biopharmaceutical company developing treatments... Full story

Yahoo Finance • 29 days ago

Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality

Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit... Full story